Table 2.
Detailed summary of data collection at study visits
| Screening visit and informed consent | |
| - Informational session about study requirements | |
| - Obtain informed consent | |
| - Verify inclusion criteria (i.e., BMI and blood pressure) | |
| - Physical exam/review of medications | |
| - Non-exercise physical activity via activPAL | |
| - Exercise calendar and Barriers screening forms | |
| - Complete metabolic panel, lipids, insulin, C-reactive protein, and blood chemistries | |
| Baseline | |
| - PWV, muscle biopsy, IVGTT, and NIRS | |
| - SF-36 and FFQ | |
| - Body weight, blood pressure, anthropometry, DEXA, and maximal exercise test | |
| Randomization | |
| - CON, MOD-INT, or HIGH-INT group | |
| Mid-intervention (12 weeks) | |
| - Waist circumference | |
| - Body weight | |
| - Maximal exercise test | |
| Follow-up (24 weeks) | |
| - Non-exercise physical activity via activPAL | |
| - PWV, muscle biopsy, IVGTT, and NIRS | |
| - SF-36 and FFQ | |
| - Complete metabolic panel, lipids, insulin, C-reactive protein, and blood chemistries | |
| - Body weight, blood pressure, anthropometry, DEXA, and maximal exercise test |
Abbreviations: BMI body mass index, CON non-exercise control (group), DEXA dual-energy x-ray absorptiometry, FFQ food frequency questionnaire, HIGH-INT high-intensity exercise (group), IVGTT intravenous glucose tolerance test, MOD-INT moderate-intensity exercise (group), NIRS near-infrared spectroscopy, PWV pulse wave velocity, SF-36 short-form health survey